Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARY P DEMERS

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1649236084
CMS profile
210735
Location
ANCHORAGE, AK

General Payments · PY2018–2024

$3,715.98

  • Reported across 197 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$272.50

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $272.50 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $74.32 4
ABBVIE INC. $45.39 2
PFIZER INC. $33.48 2
NOVARTIS PHARMACEUTICALS CORPORATION $26.40 1
GlaxoSmithKline, LLC. $26.36 1
Exact Sciences Corporation $23.64 1
E.R. Squibb & Sons, L.L.C. $23.28 1
Lilly USA, LLC $19.63 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $675.73 39
PY2019 $527.81 26
PY2020 $485.98 30
PY2021 $620.31 32
PY2022 $896.05 45
PY2023 $237.60 12
PY2024 $272.50 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.25 01/04/2024 Food and Beverage Undisputed 01/23/2026 1103623980 CMS
ABBVIE INC. $25.14 03/07/2024 Food and Beverage Undisputed 01/23/2026 1103623982 CMS
AstraZeneca Pharmaceuticals LP $20.62 02/01/2024 Food and Beverage Undisputed 01/23/2026 1105471507 CMS
AstraZeneca Pharmaceuticals LP $17.60 04/04/2024 Food and Beverage Undisputed 01/23/2026 1105701980 CMS
AstraZeneca Pharmaceuticals LP $18.50 05/02/2024 Food and Beverage Undisputed 01/23/2026 1104412809 CMS
AstraZeneca Pharmaceuticals LP $17.60 11/07/2024 Food and Beverage Undisputed 01/23/2026 1105698372 CMS
E.R. Squibb & Sons, L.L.C. $23.28 07/11/2024 Food and Beverage Undisputed 01/23/2026 1101304577 CMS
Exact Sciences Corporation $23.64 09/05/2024 Food and Beverage Undisputed 01/23/2026 1114632840 CMS
GlaxoSmithKline, LLC. $26.36 06/05/2024 Food and Beverage Undisputed 01/23/2026 1116655765 CMS
Lilly USA, LLC $19.63 08/01/2024 Food and Beverage Undisputed 01/23/2026 1135181678 CMS
Novartis Pharmaceuticals Corporation $26.40 12/03/2024 Food and Beverage Undisputed 01/23/2026 1086958715 CMS
PFIZER INC. $15.84 04/25/2024 Food and Beverage Undisputed 01/23/2026 1131326390 CMS
PFIZER INC. $17.64 10/11/2024 Food and Beverage Undisputed 01/23/2026 1132128191 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.